NYXOAH
NASDAQ: NYXH (Nyxoah SA)
Kemas kini terakhir: 5 jam lalu1.45
-1.43 (-49.65%)
| Penutupan Terdahulu | 2.88 |
| Buka | 1.73 |
| Jumlah Dagangan | 2,428,527 |
| Purata Dagangan (3B) | 44,182 |
| Modal Pasaran | 64,805,908 |
| Harga / Jualan (P/S) | 6.68 |
| Harga / Buku (P/B) | 3.23 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2026 |
| Margin Operasi (TTM) | -1,939.76% |
| EPS Cair (TTM) | -2.32 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -12.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 23.79% |
| Nisbah Semasa (MRQ) | 3.59 |
| Aliran Tunai Operasi (OCF TTM) | -55.47 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -34.10 M |
| Pulangan Atas Aset (ROA TTM) | -33.76% |
| Pulangan Atas Ekuiti (ROE TTM) | -77.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | Nyxoah SA | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.63 |
|
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 41.73% |
| % Dimiliki oleh Institusi | 25.59% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Vestal Point Capital, Lp | 31 Mar 2026 | 868,661 |
| Rossmore Private Capital | 31 Mar 2026 | 132,746 |
| Ifp Advisors, Inc | 31 Mar 2026 | 87,365 |
| Axa Investment Managers S.A. | 30 Sep 2025 | 86,142 |
| Dekabank Deutsche Girozentrale | 31 Mar 2026 | 26,200 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |